Home > Journals > Gazzetta Medica Italiana Archivio per le Scienze Mediche > Past Issues > Gazzetta Medica Italiana Archivio per le Scienze Mediche 2013 June;172(6) > Gazzetta Medica Italiana Archivio per le Scienze Mediche 2013 June;172(6):503-9

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

GAZZETTA MEDICA ITALIANA ARCHIVIO PER LE SCIENZE MEDICHE

A Journal on Internal Medicine and Pharmacology


Indexed/Abstracted in: BIOSIS Previews, EMBASE, Scopus, Emerging Sources Citation Index

 

REVIEWS  


Gazzetta Medica Italiana Archivio per le Scienze Mediche 2013 June;172(6):503-9

language: Italian

Biomarkers in calcific aortic valve disease

Incardona V. M., Dato E., Dato A. G.

Centro di Diagnostica Cardiovascolare del Dott. Dato Achille Giuseppe & C., Paternò, Catania, Italia


PDF  


Calcific aortic valve disease (CAVD) is the most common acquired valvular disorder in developed countries. CAVD ranges from mild thickening of the valve, known as aortic valve sclerosis (AVSc), to severe impairment of the valve motion, which is termed aortic valve stenosis (AVS). The prevalence of aortic sclerosis without obstruction of the left ventricular outflow is present in nearly 30% of adults over 65 years of age. The pathophysiological development of CAVD is incompletely defined. The major methods to diagnose CAVD are clinical examination, echocardiography and cardiac catheterization. Biomarkers can give useful information about the presence, severity, progression and prognosis of CAVD. These markers provide the information necessary to optimize future therapeutic interventions.

top of page

Publication History

Cite this article as

Corresponding author e-mail